On August 4, 2025, BioCardia, Inc. updated investors on the expected timing for FDA and Japan PMDA approvals of its CardiAMP® Cell Therapy System and Helix Transendocardial Delivery Catheter. This announcement highlights ongoing progress in their regulatory activities.